Search Results

There are 2532383 results for: content related to: Neoadjuvant therapy for high-risk bulky regional melanoma

  1. You have free access to this content
    Immunotherapy of cancer in 2012

    CA: A Cancer Journal for Clinicians

    Volume 62, Issue 5, September/October 2012, Pages: 309–335, John M. Kirkwood, Lisa H. Butterfield, Ahmad A. Tarhini, Hassane Zarour, Pawel Kalinski and Soldano Ferrone

    Article first published online : 10 MAY 2012, DOI: 10.3322/caac.20132

  2. Melanoma Immunotherapy

    Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine

    Volume 77, Issue 6, November/December 2010, Pages: 620–642, Shanthi Sivendran, Bradley Glodny, Michael Pan, Miriam Merad and Yvonne Saenger

    Article first published online : 23 NOV 2010, DOI: 10.1002/msj.20215

  3. You have full text access to this OnlineOpen article
    CTLA-4 blockade with ipilimumab: biology, safety, efficacy, and future considerations

    Cancer Medicine

    Luis H. Camacho

    Article first published online : 25 JAN 2015, DOI: 10.1002/cam4.371

  4. You have free access to this content
    Patterns of onset and resolution of immune-related adverse events of special interest with ipilimumab


    Volume 119, Issue 9, 1 May 2013, Pages: 1675–1682, Jeffrey S. Weber, Reinhard Dummer, Veerle de Pril, Celeste Lebbé, F. Stephen Hodi and for the MDX010-20 Investigators

    Article first published online : 7 FEB 2013, DOI: 10.1002/cncr.27969

  5. You have full text access to this OnlineOpen article
    Model-based clinical pharmacology profiling of ipilimumab in patients with advanced melanoma

    British Journal of Clinical Pharmacology

    Volume 78, Issue 1, July 2014, Pages: 106–117, Yan Feng, Eric Masson, David Dai, Susan M. Parker, David Berman and Amit Roy

    Article first published online : 20 JUN 2014, DOI: 10.1111/bcp.12323

  6. You have full text access to this OnlineOpen article
    Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma

    Annals of the New York Academy of Sciences

    Volume 1291, Issue 1, July 2013, Pages: 1–13, Jedd D. Wolchok, F. Stephen Hodi, Jeffrey S. Weber, James P. Allison, Walter J. Urba, Caroline Robert, Steven J. O'Day, Axel Hoos, Rachel Humphrey, David M. Berman, Nils Lonberg and Alan J. Korman

    Article first published online : 17 JUN 2013, DOI: 10.1111/nyas.12180

  7. You have full text access to this OnlineOpen article
    Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting


    Volume 116, Issue 7, 1 April 2010, Pages: 1767–1775, Geoffrey Y. Ku, Jianda Yuan, David B. Page, Sebastian E. A. Schroeder, Katherine S. Panageas, Richard D. Carvajal, Paul B. Chapman, Gary K. Schwartz, James P. Allison and Jedd D. Wolchok

    Article first published online : 8 FEB 2010, DOI: 10.1002/cncr.24951

  8. You have free access to this content
    Targeting cytotoxic T-lymphocyte antigen-4 (CTLA-4)


    Volume 110, Issue 12, 15 December 2007, Pages: 2614–2627, Steven J. O'Day, Omid Hamid and Walter J. Urba

    Article first published online : 14 NOV 2007, DOI: 10.1002/cncr.23086

  9. You have full text access to this OnlineOpen article
    Ipilimumab and radiation therapy for melanoma brain metastases

    Cancer Medicine

    Volume 2, Issue 6, December 2013, Pages: 899–906, Ann W. Silk, Michael F. Bassetti, Brady T. West, Christina I. Tsien and Christopher D. Lao

    Article first published online : 10 OCT 2013, DOI: 10.1002/cam4.140

  10. You have full text access to this OnlineOpen article
    Survival of melanoma patients with brain metastases treated with ipilimumab and stereotactic radiosurgery

    Cancer Medicine

    Volume 4, Issue 1, January 2015, Pages: 1–6, Karim Tazi, Amanda Hathaway, Cody Chiuzan and Keisuke Shirai

    Article first published online : 27 AUG 2014, DOI: 10.1002/cam4.315

  11. Developing melanoma therapeutics: overview and update

    Wiley Interdisciplinary Reviews: Systems Biology and Medicine

    Volume 5, Issue 3, May/June 2013, Pages: 257–271, John B. Korman and David E. Fisher

    Article first published online : 13 FEB 2013, DOI: 10.1002/wsbm.1210

  12. Ipilimumab (Yervoy®)

    Handbook of Therapeutic Antibodies

    Teresa Alonso Gordoa, Javier Puente Vázquez, Eduardo Díaz-Rubio, Pages: 1619–1644, 2014

    Published Online : 12 AUG 2014, DOI: 10.1002/9783527682423.ch59

  13. Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy

    Immunological Reviews

    Volume 224, Issue 1, August 2008, Pages: 141–165, Karl S. Peggs, Sergio A. Quezada and James P. Allison

    Article first published online : 4 AUG 2008, DOI: 10.1111/j.1600-065X.2008.00649.x

  14. Immunotherapy for metastatic melanoma

    Journal of Cellular Biochemistry

    Volume 113, Issue 3, March 2012, Pages: 725–734, Christopher R. Zito and Harriet M. Kluger

    Article first published online : 20 JAN 2012, DOI: 10.1002/jcb.23402

  15. You have free access to this content
    Side effects of systemic oncological therapies in dermatology

    JDDG: Journal der Deutschen Dermatologischen Gesellschaft

    Volume 10, Issue 7, July 2012, Pages: 475–486, Lisa Zimmer, Julia Vaubel, Elisabeth Livingstone and Dirk Schadendorf

    Article first published online : 9 MAY 2012, DOI: 10.1111/j.1610-0387.2012.07942.x

  16. You have free access to this content
    Clinical activity of ipilimumab for metastatic uveal melanoma


    Volume 119, Issue 20, 15 October 2013, Pages: 3687–3695, Jason J. Luke, Margaret K. Callahan, Michael A. Postow, Emanuela Romano, Nikhil Ramaiya, Mark Bluth, Anita Giobbie-Hurder, Donald P. Lawrence, Nageatte Ibrahim, Patrick A. Ott, Keith T. Flaherty, Ryan J. Sullivan, James J. Harding, Sandra D'Angelo, Mark Dickson, Gary K. Schwartz, Paul B. Chapman, Jedd D. Wolchok, F. Stephen Hodi and Richard D. Carvajal

    Article first published online : 2 AUG 2013, DOI: 10.1002/cncr.28282

  17. You have full text access to this OnlineOpen article
    Is there a role for immune checkpoint blockade with ipilimumab in prostate cancer?

    Cancer Medicine

    Volume 2, Issue 2, April 2013, Pages: 243–252, Edward Cha and Eric J. Small

    Article first published online : 24 FEB 2013, DOI: 10.1002/cam4.64

  18. You have free access to this content
    Ipilimumab-induced toxicities and the gastroenterologist

    Journal of Gastroenterology and Hepatology

    Accepted manuscript online: 16 JAN 2015, Robert Cheng, Adam Cooper, James Kench, Geoff Watson, William Bye, Catriona McNeil and Nicholas Shackel

    DOI: 10.1111/jgh.12888

  19. Molecularly targeted therapies for melanoma

    International Journal of Dermatology

    Volume 52, Issue 5, May 2013, Pages: 523–530, Lucinda S. Liu and Oscar R. Colegio

    Article first published online : 17 APR 2013, DOI: 10.1111/j.1365-4632.2012.05829.x

  20. You have free access to this content
    Update on monoclonal antibodies for the treatment of cancer

    Asia-Pacific Journal of Clinical Oncology

    Volume 7, Issue s1, April 2011, Pages: 20–25, Ian D DAVIS

    Article first published online : 24 MAR 2011, DOI: 10.1111/j.1743-7563.2011.01384.x